Pan-RAS inhibition remodels the pancreatic immune microenvironment resulting in diminished CD8+ T cell effector abundance and functionality, as a potential consequence of systemic pan-RAS inhibition.
Rashmi J. Kumar, E. Lasse-Opsahl, Lauren Gerbereux et al.· Cancer Research· 0 citations
Notch is a contact-dependent signaling pathway that plays critical roles in spatiotemporal patterning during embryogenesis. Beyond its role in development, Notch signaling regulates tissue patterning in adult organs in response to tissue injury or cancer. In the context of cancer, the role of Notch signaling has been...
Allison C. Bischoff, Wei Yan, Carlos E. Espinoza et al.· Cancer Research· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive type of pancreatic cancer classically driven by oncogenic KRAS mutations. It is thought to arise from precursor lesions including intraductal papillary mucinous neoplasia (IPMN) and pancreatic intraepithelial neoplasia (PanIN). We have recently reported that Pa...
J. Okoye, Rosina Carr, Carlos E. Espinoza et al.· Cancer Research· 0 citations
It is suggested that pharmacologic and genetic KRAS inhibition differentially remodel the intratumoral T cell compartment, whereas both induce similar T cell changes within the liver premetastatic niche.
Lauren Gerbereux, Rashmi Kumar, E. Lasse-Opsahl et al.· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.